Latest News and Press Releases

Kailera Therapeutics appoints 30-year biopharma industry veteran Frank Clyburn, Jr to its Board of Directors

Hengrui Pharma and Kailera today announced an oral presentation of HRS9531 Phase 3 data at ObesityWeek® 2025, the annual meeting of the Obesity Society.

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "Statistical Process Control (SPC) and Control Charts for Laboratory Compliance (Oct 14, 2025)" training has been added to ResearchAndMarkets.com's...

Preclinical Data for OPK-8801003 Demonstrate Substantially Longer Biological Half-Life with Peak Plasma Levels Comparable to Gattex®, the Only Approved GLP-2 Therapy Oral GLP-2 Tablet Could Transform...

Dublin, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The "Quality Control Laboratory Compliance - cGMPs and GLPs Course (ONLINE EVENT: October 21-22, 2025)" has been added to ResearchAndMarkets.com's...

Dublin, March 10, 2025 (GLOBE NEWSWIRE) -- The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. This seminar provides the fundamentals and the ground rules on how to...

MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Actual Veggies®, a CPG leader known for its chef-crafted veggie burgers and vegetable-forward products, today announced its $7 million Series A round of...

Dublin, Feb. 17, 2025 (GLOBE NEWSWIRE) -- The "GLP Compliance Audits: What to look out for at a New Nonclinical CRO" training has been added to ResearchAndMarkets.com's offering.This webinar will...

JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported...

Dublin, Sept. 02, 2024 (GLOBE NEWSWIRE) -- The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. The course will go through what typically goes on during an FDA...